CIK: 0001595855 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Feb 12, 2016
Total Value ($000): $239,178 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 110,000 | $12,340 | 5.2% | $45.89 | +117.9% | COM | 90400D108 |
| AXGN | AXOGEN INC | 2,120,000 | $10,600 | 4.4% | $3.33 | +48.6% | COM | 05463X106 |
| — | FIBROGEN INC | 325,000 | $9,903 | 4.1% | $25.76 | — | COM | 31572Q808 |
| GERN | GERON CORP | 1,825,000 | $8,833 | 3.7% | $2.63 | +52.6% | COM | 374163103 |
| — | MEDGENICS INC | 1,390,000 | $8,368 | 3.5% | $5.44 | — | COM NEW | 58436Q203 |
| — | IMPRIMIS PHARMACEUTICALS INC | 1,205,000 | $8,351 | 3.5% | $3098.93 | — | COM NEW | 45323A201 |
| — | PROTALIX BIOTHERAPEUTICS INC | 8,100,000 | $8,262 | 3.5% | $1.33 | — | COM | 74365AAB7 |
| — | OPHTHOTECH CORP | 105,000 | $8,246 | 3.4% | $13006.66 | — | COM | 683745103 |
| — | ARIAD PHARMACEUTICALS INC | 1,310,000 | $8,188 | 3.4% | $6983.72 | — | COM | 04033A100 |
| EGRX | EAGLE PHARMACEUTICALS INC | 85,000 | $7,537 | 3.2% | $71.99 | +9.7% | COM | 269796108 |
| — | INOTEK PHARMACEUTICALS CORP | 645,000 | $7,308 | 3.1% | $5.17 | — | COM | 45780VAA0 |
| — | BLUEPRINT MEDICINES CORP | 275,000 | $7,244 | 3.0% | $23.98 | — | COM | 09627Y109 |
| — | CARA THERAPEUTICS INC | 427,000 | $7,199 | 3.0% | $11.10 | — | COM | 140755109 |
| CDXS | CODEXIS INC | 1,600,000 | $6,768 | 2.8% | $1.98 | +84.5% | COM | 192005106 |
| — | RETROPHIN INC | 345,000 | $6,655 | 2.8% | $20.71 | — | COM | 761299106 |
| — | RELYPSA INC | 220,000 | $6,235 | 2.6% | $28.34 | — | COM | 759531106 |
| — | CEMPRA INC | 200,000 | $6,226 | 2.6% | $9402.92 | — | COM | 15130J109 |
| — | SAGE THERAPEUTICS INC | 100,000 | $5,830 | 2.4% | $55.10 | — | COM | 78667J108 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 420,000 | $5,645 | 2.4% | $8.76 | +76.5% | COM | 868459108 |
| — | DEPOMED INC | 300,000 | $5,439 | 2.3% | $18.13 | — | COM | 249908104 |
| — | ADAMAS PHARMACEUTICALS INC | 190,000 | $5,380 | 2.2% | $18.81 | — | COM | 00548A106 |
| — | AMAG PHARMACEUTICALS INC | 150,000 | $4,529 | 1.9% | $53.91 | — | COM | 00163U106 |
| — | TONIX PHARMACEUTICALS HLDG C | 565,000 | $4,334 | 1.8% | $6.52 | — | COM NEW | 890260201 |
| — | AVINGER INC | 190,000 | $4,315 | 1.8% | $13.68 | — | COM | 053734109 |
| — | AFFIMED N V | 595,000 | $4,236 | 1.8% | $13.47 | — | COM | N01045108 |
| — | FOAMIX PHARMACEUTICALS LTD | 500,000 | $4,055 | 1.7% | $8.16 | — | SHS | M46135105 |
| — | CYTRX CORP | 1,440,000 | $3,816 | 1.6% | $2.37 | — | COM PAR $.001 | 838828509 |
| — | LA JOLLA PHARMACEUTICAL CO | 140,000 | $3,780 | 1.6% | $27.00 | — | COM PAR $.0001 2 | 503459904 |
| TGTX | TG THERAPEUTICS INC | 300,000 | $3,579 | 1.5% | $14.60 | -13.5% | COM | 88322Q108 |
| — | INTEC PHARMA LTD JERUSALEM | 630,000 | $3,377 | 1.4% | $5.60 | — | SHS | M53644106 |
| — | AMARIN CORP PLC | 1,760,000 | $3,326 | 1.4% | $2.34 | — | SPONS ADR NEW | 023111206 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 55,000 | $3,111 | 1.3% | $30.55 | +66.4% | COM | 64125C109 |
| — | FLAMEL TECHNOLOGIES SA | 250,000 | $3,053 | 1.3% | $17.52 | — | SPONSORED ADR | 338488109 |
| — | AGILE THERAPEUTICS INC | 300,000 | $2,928 | 1.2% | $7.00 | — | COM | 00847L100 |
| — | CORIUM INTL INC | 355,000 | $2,883 | 1.2% | $8.12 | — | COM | 21887L107 |
| — | TRILLIUM THERAPEUTICS INC | 210,000 | $2,648 | 1.1% | $9.00 | — | COM NEW | 89620X506 |
| XENE | XENON PHARMACEUTICALS INC | 300,000 | $2,412 | 1.0% | $9.26 | -7.4% | COM | 98420N105 |
| — | XOMA CORP DEL | 1,700,000 | $2,261 | 0.9% | $1.44 | — | COM | 98419J107 |
| — | ZOGENIX INC | 150,000 | $2,211 | 0.9% | $1.68 | — | COM NEW | 98978L105 |
| — | ALDER BIOPHARMACEUTICALS INC | 65,000 | $2,147 | 0.9% | $32.96 | — | COM | 014339105 |
| — | NABRIVA THERAPEUTICS AG | 220,000 | $2,116 | 0.9% | $9.62 | — | SPONSORED ADR | 62957M104 |
| — | AURIS MED HLDG AG | 375,000 | $1,834 | 0.8% | $4.86 | — | COM | H03579101 |
| — | TENAX THERAPEUTICS INC | 540,000 | $1,771 | 0.7% | $3.68 | — | COM | 88032L100 |
| — | CYNAPSUS THERAPEUTICS INC | 110,000 | $1,682 | 0.7% | $15.52 | — | COM PAR NO PAR | 23257Y859 |
| — | ACCELERATED DIAGNOSTICS INC | 75,000 | $1,612 | 0.7% | $19162.23 | — | COM | 00430H102 |
| CLLS | CELLECTIS S A | 50,000 | $1,552 | 0.6% | $31.04 | — | SPONSORED ADS | 15117K103 |
| MGNX | MACROGENICS INC | 35,000 | $1,084 | 0.5% | $30.38 | 0.0% | COM | 556099109 |
| — | VITAE PHARMACEUTICALS INC | 58,500 | $1,059 | 0.4% | $18.10 | — | COM | 92847N103 |
| — | IMMUNOMEDICS INC | 290,000 | $890 | 0.4% | $3.07 | — | COM | 452907108 |
| — | ACHAOGEN INC | 125,000 | $718 | 0.3% | $5.74 | — | COM | OO4449104 |
| SGMO | SANGAMO BIOSCIENCES INC | 60,000 | $548 | 0.2% | $7.71 | 0.0% | COM | 800677106 |
| — | EVOKE PHARMA INC | 130,000 | $429 | 0.2% | $474.90 | — | COM | 30049G104 |
| — | BIOLINERX LTD | 250,000 | $325 | 0.1% | $1426.15 | — | SPONSORED ADR | 09071M106 |